LiPlasome Pharma
LiPlasome, a biotech company focused on oncology, provides a liplasomal reformulation of anticancer drugs on the market.
LiPlasome Pharma is a company in biotechnology, health care, oncology, pharmaceutical based in European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA), founded in 2002.
As a business in biotechnology, health care, oncology, pharmaceutical, LiPlasome Pharma is listed here with the public details available about it.
European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA) is where the company is located.
The company is listed at the Series_B stage of development.
Its team size is recorded as c_00011_00050 employees.
It has disclosed roughly $8M in funding.
| Sector | Biotechnology, Health Care, Oncology, Pharmaceutical |
|---|---|
| Headquarters | European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA) |
| Founded | 2002 |
| Employees | c_00011_00050 |
| Stage | series_b |
| Total funding | $8,010,000 |
Website: www.liplasome.com
Browse related
Create a free account